555 related articles for article (PubMed ID: 25381325)
21. Fabry disease: focus on cardiac manifestations and molecular mechanisms.
Perrot A; Osterziel KJ; Beck M; Dietz R; Kampmann C
Herz; 2002 Nov; 27(7):699-702. PubMed ID: 12439642
[TBL] [Abstract][Full Text] [Related]
22. Usefulness of tissue Doppler on early detection of cardiac disease in Fabry patients and potential role of enzyme replacement therapy (ERT) for avoiding progression of disease.
Zamorano J; Serra V; Pérez de Isla L; Feltes G; Calli A; Barbado FJ; Torras J; Hernandez S; Herrera J; Herrero JA; Pintos G
Eur J Echocardiogr; 2011 Sep; 12(9):671-7. PubMed ID: 21810826
[TBL] [Abstract][Full Text] [Related]
23. Kidney transplantation and enzyme replacement therapy in patients with Fabry disease.
Cybulla M; Kurschat C; West M; Nicholls K; Torras J; Sunder-Plassmann G; Feriozzi S
J Nephrol; 2013; 26(4):645-51. PubMed ID: 23023720
[TBL] [Abstract][Full Text] [Related]
24. Kidney transplantation in patients with Fabry disease.
Cybulla M; Walter KN; Schwarting A; Divito R; Feriozzi S; Sunder-Plassmann G;
Transpl Int; 2009 Apr; 22(4):475-81. PubMed ID: 19207191
[TBL] [Abstract][Full Text] [Related]
25. Reproducibility of native myocardial T1 mapping in the assessment of Fabry disease and its role in early detection of cardiac involvement by cardiovascular magnetic resonance.
Pica S; Sado DM; Maestrini V; Fontana M; White SK; Treibel T; Captur G; Anderson S; Piechnik SK; Robson MD; Lachmann RH; Murphy E; Mehta A; Hughes D; Kellman P; Elliott PM; Herrey AS; Moon JC
J Cardiovasc Magn Reson; 2014 Dec; 16(1):99. PubMed ID: 25475749
[TBL] [Abstract][Full Text] [Related]
26. Reduced Cardiovascular Reserve in Chronic Kidney Failure: A Matched Cohort Study.
Ting SM; Hamborg T; McGregor G; Oxborough D; Lim K; Koganti S; Aldridge N; Imray C; Bland R; Fletcher S; Krishnan NS; Higgins RM; Townend J; Banerjee P; Zehnder D
Am J Kidney Dis; 2015 Aug; 66(2):274-84. PubMed ID: 25900597
[TBL] [Abstract][Full Text] [Related]
27. Many Faces of Fabry's Cardiomyopathy.
Jain R; Kalvin L; Johnson B; Muthukumar L; Khandheria BK; Tajik AJ
JACC Cardiovasc Imaging; 2018 Apr; 11(4):644-647. PubMed ID: 29361493
[No Abstract] [Full Text] [Related]
28. [Risk factors and pathogenetic mechanisms of left ventricular hypertrophy in progressive chronic kidney disease and after transplantation of the kidney].
Tomilina NA; Storozhakov GI; Gendlin GE; Badaeva SV; Zhidkova DA; Kim IG; Borisovskaia SV; Loss KE; Fedorova ND
Ter Arkh; 2007; 79(6):34-40. PubMed ID: 17684964
[TBL] [Abstract][Full Text] [Related]
29. Early detection of Fabry cardiomyopathy by tissue Doppler imaging.
Pieroni M; Chimenti C; Ricci R; Sale P; Russo MA; Frustaci A
Circulation; 2003 Apr; 107(15):1978-84. PubMed ID: 12668521
[TBL] [Abstract][Full Text] [Related]
30. Effects of enzyme-replacement therapy in patients with Anderson-Fabry disease: a prospective long-term cardiac magnetic resonance imaging study.
Imbriaco M; Pisani A; Spinelli L; Cuocolo A; Messalli G; Capuano E; Marmo M; Liuzzi R; Visciano B; Cianciaruso B; Salvatore M
Heart; 2009 Jul; 95(13):1103-7. PubMed ID: 19372091
[TBL] [Abstract][Full Text] [Related]
31. The heart in Anderson Fabry disease.
Kampmann C; Wiethoff CM; Perrot A; Beck M; Dietz R; Osterziel KJ
Z Kardiol; 2002 Oct; 91(10):786-95. PubMed ID: 12395219
[TBL] [Abstract][Full Text] [Related]
32. Myocardial Storage, Inflammation, and Cardiac Phenotype in Fabry Disease After One Year of Enzyme Replacement Therapy.
Nordin S; Kozor R; Vijapurapu R; Augusto JB; Knott KD; Captur G; Treibel TA; Ramaswami U; Tchan M; Geberhiwot T; Steeds RP; Hughes DA; Moon JC
Circ Cardiovasc Imaging; 2019 Dec; 12(12):e009430. PubMed ID: 31826677
[TBL] [Abstract][Full Text] [Related]
33. Nephropathy in males and females with Fabry disease: cross-sectional description of patients before treatment with enzyme replacement therapy.
Ortiz A; Oliveira JP; Waldek S; Warnock DG; Cianciaruso B; Wanner C;
Nephrol Dial Transplant; 2008 May; 23(5):1600-7. PubMed ID: 18175781
[TBL] [Abstract][Full Text] [Related]
34. Left atrial strain associated with alterations in cardiac diastolic function in patients with end-stage renal disease.
Li C; Zhang J; Fan R; Li W; Liu Y; Liu D; Lin H; Yao F; Ye M; He W
Int J Cardiovasc Imaging; 2019 Oct; 35(10):1803-1810. PubMed ID: 31123845
[TBL] [Abstract][Full Text] [Related]
35. Does left ventricular function predict cardiac outcome in Anderson-Fabry disease?
Spinelli L; Giugliano G; Pisani A; Imbriaco M; Riccio E; Russo C; Cuocolo A; Trimarco B; Esposito G
Int J Cardiovasc Imaging; 2021 Apr; 37(4):1225-1236. PubMed ID: 33211238
[TBL] [Abstract][Full Text] [Related]
36. Anderson-Fabry disease and the heart.
O'Mahony C; Elliott P
Prog Cardiovasc Dis; 2010; 52(4):326-35. PubMed ID: 20109602
[TBL] [Abstract][Full Text] [Related]
37. Changes in left ventricular filling parameters before and after dialysis in patients with end stage renal disease.
Ersbøll M; Raja AA; Warming PE; Nielsen TL; Plesner LL; Dalsgaard M; Schou M; Rydahl C; Brandi L; Iversen K
Int J Cardiovasc Imaging; 2019 Sep; 35(9):1673-1681. PubMed ID: 31093896
[TBL] [Abstract][Full Text] [Related]
38. Kidney transplant outcomes in patients with Fabry disease.
Shah T; Gill J; Malhotra N; Takemoto SK; Bunnapradist S
Transplantation; 2009 Jan; 87(2):280-5. PubMed ID: 19155985
[TBL] [Abstract][Full Text] [Related]
39. Tei index in fabry disease.
Niemann M; Breunig F; Beer M; Hu K; Liu D; Emmert A; Herrmann S; Ertl G; Wanner C; Takenaka T; Tei C; Weidemann F
J Am Soc Echocardiogr; 2011 Sep; 24(9):1026-32. PubMed ID: 21719255
[TBL] [Abstract][Full Text] [Related]
40. New insights in cardiac structural changes in patients with Fabry's disease.
Linhart A; Palecek T; Bultas J; Ferguson JJ; Hrudová J; Karetová D; Zeman J; Ledvinová J; Poupetová H; Elleder M; Aschermann M
Am Heart J; 2000 Jun; 139(6):1101-8. PubMed ID: 10827394
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
